Harbor MedTech

Executive Summary

Harbor MedTech is a privately held regenerative medicine company headquartered in Irvine, California, focused on developing advanced orthopedic soft tissue repair solutions. The company's proprietary BriDGE® technology converts intact Type-1 collagen into a stabilized, bio-friendly matrix that triggers the patient’s natural healing cascade. Founded in 2016, Harbor MedTech targets a significant unmet need in sports medicine and orthopedic surgery, where current repair methods often fall short in restoring native tissue function and promoting full recovery. The technology's ability to harness the body's own healing mechanisms positions it as a potential game-changer in the field of soft tissue regeneration, with applications spanning rotator cuff repairs, ACL reconstruction, and other tendon/ligament injuries.

Upcoming Catalysts (preview)

• Q2 2027Initiation of First-in-Human Clinical Trial40% success
• Q4 2026FDA Pre-IND Meeting or Investigational Device Exemption (IDE) Submission55% success
• Q1 2027Strategic Partnership or Licensing Agreement with Major Orthopedic Company30% success